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In Vitro and In Vivo Characterization
of Pentaerythritol Triacrylate-co-Trimethylolpropane
Nanocomposite Scaffolds as Potential
Bone Augments and Grafts
Cong Chen, MS,1,* Leah Garber,2,* Mollie Smoak,1 Carmel Fargason,3 Thomas Scherr, PhD,4 Caleb Blackburn,2
Sasha Bacchus,2 Mandi J. Lopez, PhD,3 John A. Pojman, PhD,2 Fabio Del Piero, PhD,5 and Daniel. J. Hayes, PhD1

A thiol-acrylate-based copolymer synthesized via an amine-catalyzed Michael addition was studied in vitro and
in vivo to assess its potential as an in situ polymerizing graft or augment in bone defect repair. The blends of
hydroxyapatite (HA) with pentaerythritol triacrylate-co-trimethylolpropane (PETA), cast as solids or gas
foamed as porous scaffolds, were evaluated in an effort to create a biodegradable osteogenic material for use as
a bone-void-filling augment. Osteogenesis experiments were conducted with human adipose-derived mesenchymal stromal cells (hASCs) to determine the ability of the material to serve as an osteoinductive substrate.
Poly(e-caprolactone) (PCL) composites PCL:HA (80:20) (wt/wt%) served as the control scaffold, while the
experimental scaffolds included PETA:HA (100:0), (85:15), (80:20), and (75:25) composites (wt/wt%). The
results indicate that PETA:HA (80:20) foam composites had higher mechanical strength than the corresponding
porous PCL:HA (80:20) scaffolds made by thermo-precipitation method, and in the case of foamed composites,
increasing HA content directly correlated with increased yield strength. For cytotoxicity and osteogenesis
experiments, hASCs cultured for 21 days on PETA:HA scaffolds in stromal medium displayed the greatest
number of live cells compared with PCL:HA composites. Moreover, hASCs cultured on foamed PETA:HA
(80:20) scaffolds resulted in the greatest mineralization, increased alkaline phosphatase (ALP) expression, and
the highest osteocalcin (OCN) expression after 21 days. Overall, the PETA:HA (80:20) and PETA:HA (85:15)
scaffolds, with 66.38% and 72.02% porosity, respectively, had higher mechanical strength and cytocompatibility compared with the PCL:HA control. The results of the 6-week in vivo biocompatibility study using a
posterior lumbar spinal fusion model demonstrate that PETA:HA can be foamed in vivo without serious adverse
effects at the surgical site. Additionally, it was demonstrated that cells migrate into the interconnected pore
volume and are found within centers of ossification.

Introduction

F

or the past several decades, the standard treatment
to augment or accelerate bone regeneration has been the
implantation of bone grafts.1 Allogeneic bone grafts are
costly, require time-consuming bone banking procedures,
and have the potential for disease transmission. Autogenous
bone grafts have long been used as bone replacements but
require additional surgeries, which increase the risk of donor

site morbidity and the burden on health care providers.2
Moreover, these techniques do not address the need for a
clinically convenient and biodegradable method for conformally filling a critical-sized bone defect while providing
mechanical support and biological cues necessary to promote bone regrowth. Artificial composite scaffolds, whether
bioderived, synthetic, or hybrids, while studied extensively
as alternatives for bone grafting and augmentation, have
yet to see wide clinical adoption.3 Composite structures with
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calcium phosphates and magnesium silicates composing the
bioactive ceramic portion have been studied thoroughly to
improve both the mechanical and osteogenic properties of
scaffolds but an in situ polymerizing, biodegradable bone
augment or graft with biomimetic morphology and mechanical properties remains elusive.3–5 An initial study
conducted by our group demonstrated the formation of a
porous interconnected scaffold derived from the product of
an amine-catalyzed Michael addition polymerization reaction.6 This thiol-acrylate reaction proceeds through a nonradical, step-growth process initiated by an amine/acrylate
comonomer that is consumed in the reaction and incorporated into the growing polymer. Porous composite scaffolds
made with this system were found to support human mesenchymal stromal/stem cell growth and to possess similar
mechanical properties to cortical bone.7
The fabrication method of a scaffold can have a substantial impact on mechanical properties and biofunctionality by controlling porosity and interconnectivity. These
factors influence cell attachment, proliferation, extracellular matrix production, and the transport of nutrients and
wastes.8–12 Solid freeform fabrication, thermal precipitation,
gas foaming, and solvent casting followed by particulate
leaching are the common approaches for making porous
scaffolds for bone repair.8,9 Except for gas foaming, these
methods are not readily applicable to thermoset polymers
due to their crosslinking densities and viscoelastic properties. Gas porogens and foaming apparatuses have the potential to be readily adapted to filling conformal defects in a
clinical environment, similar to other surgical devices in
use, such as fibrin sealant13,14 and bone putty.15
Herein we report on the in vitro characterization of the
mechanical and osteoinductive properties of a gas-foamed
nanocomposite scaffold consisting of a thiol-acrylate copolymer with nanoscale hydroxyapatite (HA) inclusions.
Scaffolds were prepared using a gas-phase propellant and
foaming agent to investigate the relationship of scaffold
composition to morphology, mechanical properties, cytocompatibility, and osteogenic properties. The impact of
varying HA concentration in the pentaerythritol triacrylateco-trimethylolpropane (PETA) polymer on morphology is
illustrated using scanning electron microscopy (SEM) and
micro-computed tomography (micro-CT) imaging. Mechanical testing was conducted to determine the compressive yield strength and modulus of the material. To evaluate
cytocompatibility and osteogenic activity, human adiposederived mesenchymal stromal cells (hASCs) were used as a
model cell type. Metabolic activity, DNA content, calcium
deposition, and the expression of the osteogenic markers
alkaline phosphatase (ALP) and osteocalcin (OCN) were
quantified with respect to scaffold composition. A 6-week
in vivo study was also conducted to assess the basic biocompatibility of the foamed composite and the feasibility of
in situ foaming for a boney fusion model.
Materials and Methods
Preparation of thiol-acrylate materials

All chemicals were used as received; trimethylolpropane
tris(3-mercaptopropionate) (TMPTMP) was obtained from
Sigma-Aldrich, diethylamine (DEA) (99% purity) from AGROS
organics, and pentaerythritol triacrylate from Alfa Aesar.
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Scaffolds were prepared by formulating PETA with 16.1%
DEA and adding TMPTMP in a 1:1 molar functionality ratio,
followed by mixing with a stir rod for 3 h as previously described.6 Several concentrations of copolymer PETA with HA
were studied; the first number in the abbreviation connotes the
polymer content while the second number provides the
amount of HA found in the composite as a wt/wt percentage
(100:0, 85:15, 80:20, and 75:25). The mixtures were cast into
cylindrical molds (5 · 10 mm2) to form a solid scaffold. The
foamed composite copolymer was prepared by pouring the
PETA and HA (150 g in total) into a 250-mL pressurized
canister using 7-g-compressed nitrous oxide as a gas foaming
agent. The foamed composite copolymer was expelled into
the same cylindrical molds used for solid casting.
Mechanical testing

Solid and foamed scaffolds, molded to 6 mm (diameter) · 12 mm (height) cylinder shape, were tested to determine
maximal compressive strength and modulus. All scaffolds—
solid, gas foamed, or thermally precipitated—were subjected
to compression, and the ultimate compressive strength was
reported at 30% strain. A universal testing machine (Instron
Model 5696) was used at an extension rate of 0.5 mm/min.6
Morphological analysis

All of the scaffolds were placed on the EMS550X sputter
coater, which applied a conductive platinum coating for
4 min followed by standard SEM analysis. Human cadaver
bone from knee area was obtained under LSU exempted IRB
protocol HE 13-10 from the Louisiana State University
(LSU) Health Science Center.
Micro-CT analysis

Four PETA:HA (100:0), (85:15), (80:20), and (75:25)
foams were fabricated by pressurized extrusion foaming and
prepared as previously described.6 The imaging was conducted at the Center for Advanced Microstructures and
Devices (Louisiana State University) using a tomography
beamline with 13 keV monochromatic X-rays with a 2.5 mm/
px resolution. Projection exposure time varied from 2 to 4 s
with Dy = 0.25 corresponding to the number of image slices
(520). Reconstruction data were 16-bit signed integer with
mean air intensity scaled to zero.
Avizo 7.0.1 (Visualization Services Group) generated the
volume renderings from the three-dimensional (3D) data of
the four foamed samples with two overlapping subvolumes
displayed simultaneously. The blue-green colormap represents
the HA inclusions, and the red-orange colormap represents the
copolymer foam. Image J generated two-dimensional (2D)
orthogonal slices possessing gray colormap settings using the
same data with a scale equivalent to the 3D rendering. An
approximate pore size was also measured using Image J. The
orthogonal and micro-CT datasets were directly comparable,
both as an aggregate dataset and as slices.
HA distribution and porosity calculation based
on micro-CT

HA distribution analysis method is described in detail in
Supplementary Data 1 section (Supplementary Data are
available online at www.liebertpub.com/tea). To analyze the
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porosity of the 3D data, 2D slices were read into a custom
MATLAB code. For each slice the grayscale image was
thresholded using Otsu’s method16 and then converted into a
binary image. Morphological operations were performed to
remove small imaging artifacts, and isolate interior and
exterior pores. After quantifying solid and void pixels, poV
rosity was calculated as follows: / ¼ Vporespores
þ Vsolid · 100%
Adult stem cell isolation and culture

Liposuction aspirates from subcutaneous adipose tissue
were obtained from three healthy adult subjects (man = 1
and women = 2) undergoing elective procedures. All tissues
were obtained with informed consent under a clinical protocol reviewed and approved by the institutional review
board at the LSU Pennington Biomedical Research Center
and used under an exempted protocol at LSU A&M College.
Isolation of hASCs was performed as published previously.12 Passage 2 of each individual was used for in vitro
hASC osteogenesis evaluation on tissue-culture-treated
plastic or on scaffolds of different compositions. In both
cases, hASCs were cultured in either stromal (control—
Dulbecco’s modified Eagle’s medium [DMEM], 10% fetal
bovine serum [FBS], and 1% triple antibiotic solution) or
osteogenic (DMEM, 10% FBS, 0.1 mM dexamethasone,
50 mM ascorbate-2-phosphate, 10 mM b-glycerophosphate,
and 1% triple antibiotic solution) media for up to 21 days
with media maintenance performed three times a week.
hASCs loading on scaffolds and culture

All types of scaffolds were either molded or sculpted into
5 mm (diameter) · 10 mm (height) cylinder shape and gas
sterilized afterward. All the scaffolds were then submerged
in stromal medium for 1 h before loading the hASCs. The
same amount of second cell passages from all donors (n = 3)
were pooled and directly loaded on a single face of each
scaffold type at a concentration of 1.0 · 104 cells/mL for total
volume of 5 mL. After 30 min of incubation in a saturated
humidity atmosphere incubator at 37C and 5% CO2, the
same volume of hASCs containing solution were directly
applied on the opposite side of each scaffold as previously
described.12 Control groups included poly(e-caprolactone)
(PCL):HA (100:0 and 80:20) scaffolds. Experimental groups
included PETA:HA (100:0, 85:15, 80:20, and 75:25) scaffolds. Scaffolds loaded with hASCs were immediately
transferred to 48-well plates and cultured in stromal or osteogenic media for 21 days. Cell medium was changed every
2–3 days. Triplicates were performed for each assay.
In vitro hASCs metabolic activity on scaffolds

AlamarBlue (Life Technologies) is a useful measure of
metabolic activity and is frequently used as an analog of cell
viability and proliferation. All scaffold samples were seeded
with hASCs and cultured in stromal or osteogenic media for
21 days. The AlamarBlue conversion was measured at 7,
14, and 21 days. The scaffolds were removed from culture,
washed three times in phosphate-buffered saline, and incubated with 10% AlamarBlue in Hank’s balanced salt solution without phenol red (pH 7) for 90 min. The fluorescence
of three aliquots (100 mL) from each scaffold was measured
at an excitation wavelength of 530 nm and an emission

CHEN ET AL.

wavelength of 595 nm using a fluorescence plate reader
(Wallac 1420 multilabel HTS counter).
Alizarin red staining

hASCs calcium deposition (triplicates of scaffolds alone
and cell-scaffolds) was assessed after 7, 14, and 21 days of
culture in control or osteogenic medium based on alizarin
red staining. Wells were washed with 0.9% NaCl and fixed
with 70% ethanol. Wells were stained with 2% alizarin red
for 10 min and washed with deionized water. Wells were
destained with 10% cetylpyridinium chloride monohydrate
for 4 h at room temperature with constant agitation. Results
were normalized to values from scaffolds cultured without
cells for the same time periods.
In vitro quantification of DNA on scaffolds

Total DNA content was used to determine the number of
cells on each scaffold as previously described.17 After triplicates of each scaffold were minced by a scalpel and the DNA
was digested with 0.5 mL of 0.5 mg/mL proteinase K (SigmaAldrich) at 56C overnight, aliquots (50 mL) were mixed with
equal volumes of 0.1 g/mL Picogreen dye solution (Invitrogen) in 96-well plates. Samples were then excited at 480 nm
with a plate reader (Wallac 1420 multilabel HTS counter).
Scaffolds without cells were used as negative controls.
Quantitative real-time polymerase chain reaction

Total RNA was extracted from triplicates of cell-scaffold
constructs as previously described.12 cDNA was synthesized
from total RNA using EcoDry Premix (ClonTech). Realtime quantitative reverse transcription polymerase chain
reaction was performed using 2 · iTaq SYBR green supermix with ROX (Bio-Rad) and primers for ALP and
OCN12 to quantify osteogenic target gene expression of
hASCs loaded to scaffolds and cultured in either stromal or
osteogenic media for 7, 14, and 21 days. Reactions were
performed with an MJ Mini Thermal Cycler (Bio-Rad).
The sequences of PCR primers (forward and backward, 50–
30) were as follows: ALP, 5¢-AATATGCCCTGGAGCT
TCAGAA-3¢ and 5¢-CCATCCCATCTCCCAGGAA-3¢; OCN,
5¢-GCCCAGCGGTGCAGAGT-3¢ and 5¢-TAGCGCCTGGGT
CTCTTCAC-3¢. Samples were normalized (DCt) against the
house keeping gene 18S rRNA and the - DDCt value of ALP
and OCN in scaffolds cultured in osteogenic and control media
was calculated using the DDCt method.18
Statistical analysis

All results were expressed as mean – standard error of
mean. Data were analyzed with one-way analysis of variance, followed by Tukey’s minimum significant difference
post hoc test for pairwise comparisons of main effects. For
all comparisons, a p-value < 0.05 was considered significant.
In vivo study
Scaffold preparation and surgical implantation. Five male
Fischer rats (Harlan Sprague-Dawley) were randomly assigned to three different treatments: (i) one rat was implanted
with presculpted PETA + 20% HA, (ii) three rats were implanted with PETA + 20% foamed in situ, or (iii) one rat was
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implanted with PETA + 0% HA foamed in situ. Stock/HA and
TMPTMP/HA prepolymer mixture was placed into a 250-mL
pressurized spray canister with 7-g-compressed nitrous oxide as
a gas foaming agent. The foamed composite copolymer was
expelled from the canister onto a sterile surface. The solid
composite was cut into a rectangle with dimensions (15 · 10 ·
1 mm3) for rat number 1. For rats 2, 3, and 4, the prepolymer mixture was prepared as described previously and
foamed into a 5-mL syringe for surgical application. The
process was the same for rat 5, but the formulation did not
contain HA.
The rat posterolateral lumbar spinal fusion surgery was
performed as previously described.19 Prior to general anesthesia, rats received a subcutaneous injection of 0.5 mg/kg
butorphanol (Torbugesic; Fort Dodge Animal Health) and
0.02 mg/kg glycopyrrolate (Robinul-V; Fort Dodge Animal
Health). Isoflurane was administered 20 min later in an induction chamber to induce anesthesia. The isoflurane was
maintained at 1.5% via nose cone on a Bain circuit for the
remainder of the procedure. The lumbar region was clipped
and aseptically prepared with 70% isopropanol and betadine. A posterior midline skin incision was made over the
lumbar spine. Two fascial incisions were made 3-mm lateral
and parallel to the dorsal spinus processes. The L4 and L5
transverse processes were exposed with sharp and blunt
dissection. A scalpel was used to decorticate each transverse
process. Surgical sites were thoroughly lavaged with physiologic saline. In rat 1, solid scaffolds were placed adjacent
to both sides of the spine such that they spanned between the
midpoint of each transverse process. For the remaining rats,
3 mL of each foamed scaffold was applied so that scaffold
spanned between the center of each transverse process next
to the spine. Fascial and subcutaneous incisions were closed
separately with 3-0 polyglactin 910 (Vicryl; Ethicon) in a
simple continuous pattern. Closure of the fascia around
the implants effectively filled any potential space. A subcutaneous/subcuticular suture pattern was used to approximate skin edges, and tissue adhesive was used for skin
closure (Vetbond; 3M). Scaffolds were harvested 3 weeks
(rat 3) or 6 weeks (rats 1, 2, 4, and 5) after implantation
following euthanasia by CO2 asphyxiation.20 At 3 weeks, no
significant results were shown in radiographs, micro-CT, or
histology analysis. Therefore, no results from rat 3 were
reported in the ‘‘Results’’ and ‘‘Discussion’’ sections.
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Micro-CT analysis. Immediately postmortem, 2D microCT imaging was performed (40 kV and 540 ms) to obtain
0.04-mm slices every 0.9 throughout a 360 rotation
(SkyScan 1074; Skyscan n.v.). Three-dimensional files were
reconstructed from 2D images. Measurements of 2D and 3D
images were performed with Avizo Standard packages
(FEI Visualization Sciences Group).
A density line was first drawn in void space with no tissue
to measure the optical density (OD) of the image background. The line was then moved to L3 of the specimen’s
vertebral column to determine the OD of the tissue unaffected by the surgery. Lastly, the density line was moved
between L4 and L5 of the specimen’s vertebral column to
calculate the OD of the area treated by the scaffolds. The
density of the area treated by the implant was normalized by
the densities of the void space and the unaffected bone region in order to calculate the percentage of bone growth
present in each specimen.20

OD ¼ log

255
Pixel value

ODTreated
· 100 ¼ % new growth
ODUntreated

Histology. Following imaging, spines were cut into half
and fixed in neutral buffered formalin. One half of each
spine was decalcified and paraffin embedded and longitudinal sections (5 mm) were stained with hematoxylin and
eosin. Microarchitecture was evaluated using Olympus
BX46 microscope.
Results
SEM analysis

The foamed scaffold samples were analyzed using SEM
to examine the trends in morphology. The morphology of
the foam containing 0–20% HA was similar to cancellous
human cadaver bone (Fig. 1). The average pore diameters of
PETA:HA 100:0 and 85:15 scaffolds were 250–300 mm,
with no significant difference between the two. PETA:HA
80:20 had a slightly smaller pore diameter of 150–200 mm.
The pore diameter of PETA:HA 75:25 was only 70–100 mm.
PETA:HA 70:30 had a pore diameter of < 50 mm. It is apparent from Figure 1 that HA does not affect pore size
significantly until the HA content reaches 25% or greater.
The viscosity of the polymer mixture during the fabrication

FIG. 1. Scanning electron microscopy analysis of pentaerythritol triacrylate-co-trimethylolpropane (PETA):hydroxyapatite (HA) (100:0), (85:15), (80:20), and (75:25) scaffolds.
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FIG. 2. Avizo rendering pictures (three-dimensional and two-dimensional [2D]) of micro-computed tomography (microCT) data of scaffolds. The blue-green colormap represents the HA inclusions, and the red-orange colormap represents the
copolymer foam. (A, B) Poly(e-caprolactone) (PCL):HA (100:0), (C, D) PCL:HA (80:20), (E, F) PETA:HA (100:0), (G, H)
PETA:HA (85:15), (I, J) PETA:HA (80:20), (K, L) and PETA:HA (75:25) scaffolds. Each scale bar in the 2D pictures
indicates 500 mm. Color images available online at www.liebertpub.com/tea
process increased, reducing N2O expansion in the polymer
mixture. Additionally, HA content above 25% causes increased pore wall thickness and an apparent reduction in
scaffold interconnectivity.
Micro-CT analysis, HA distribution,
and porosity calculation

There is a limitation associated with the amount of material that SEM can qualitatively analyze, reducing the
generalizability of the data. To address this limitation, the
interconnectivity, pore volume, and ceramic phase distribution of HA-PETA copolymer composites and PCL (control) were further analyzed by micro-CT. Micro-CT image
analysis is a more sensitive method for estimating porosity
of materials when compared to SEM, flow porosimetry, and

gas adsorption.21 Volume renderings (Fig. 2) were generated
from PETA and PCL composite foam 3D data using Avizo
7.0.1 (Visualization Services Group). Two overlapping subvolumes were rendered simultaneously, one with a red-orangewhite colormap corresponding to thiol-acrylate foam, and
another with a blue-green colormap corresponding to ceramic
HA additives. For PETA:HA (85:15, 80:20, and 75:25), ceramics on average are 183.4 – 93.9, 221.3 – 102.3, and 206.8 –
114.7 voxels away from an edge of the scaffold while they are
282.7 – 91.6, 355.9 – 114.7, and 336.8 – 101.8 voxels away
from the center of the scaffold, respectively. For all types of
PETA:HA scaffolds, the HA ceramics were on average closer
to the edge of the scaffold than to the center of it, indicating
that ceramic particles were evenly distributed rather than
clustered around the center of the scaffolds. Figure 3 shows
HA histograms of the distance from each ceramic to the center

FIG. 3. HA histograms of distance from each ceramic to the center of mass of the scaffold. (A) PETA:HA (85:15), (B)
PETA:HA (80:20), and (C) PETA:HA (75:25).
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of mass of the scaffold; they display a very Gaussian-looking
distribution around the mean. This indicates that there are
nearly equal amounts of ceramics distributed spatially around
this mean distance.
The porosity of PETA:HA (100:0, 85:15, and 80:20) is
66.9%, 72.0%, and 66.4%, respectively (Fig. 4A). It should
be noted that an apparent transition in morphology occurred
between 20% and 25% HA inclusions. As HA concentration
increased from 20% to 25%, the porosity decreased significantly from 66.4% to 44.7%. When HA concentration
reaches 25%, the pore size is substantially reduced and the
interconnected void volume appeared to decrease, resulting
in a structure similar to a closed-cell foam (Fig. 2K, L). This
is attributed to increased polymer solution viscosity correlated with reduced N2O expansion and mobility. In addition,
the inclusion of 20% HA to PCL scaffolds increased the
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porosity from 78.0% (PCL:HA 100:0) to 87.6% (PCL:HA
80:20) (Fig. 2A, C).
Mechanical testing

Figure 4B shows the compressive yield strength of the
foamed and solid PCL:HA (100:0 and 80:20) and PETA:HA
(100:0, 85:15, 80:20, and 75:25) samples. Compressive
strength of solid PCL:HA (100:0 and 80:20) samples is significantly higher than corresponding PETA:HA (100:0 and
80:20) samples. When comparing among porous scaffolds,
PETA:HA (100:0 and 80:20) scaffolds are either the same as
or stronger than PCL:HA (100:0 and 80:20). The compressive strength of the foamed PETA:HA steadily increased with
increasing HA content; however, the solid samples did not
follow a similar trend. The addition of 15% HA in the foam
resulted in a significant increase in compressive strength
compared with the control samples and increasing the HA
content beyond 15% correlated with increased compressive
strength. Conversely, solid PETA:HA (85:15, 80:20, and
75:25) composite scaffolds exhibited approximately the same
compressive strength for all HA-containing samples. It is
believed that the porosity (Fig. 4A) is responsible for the
different trends between solid and foamed scaffolds.
hASCs metabolic activity and proliferation on scaffolds
cultured in control and osteogenic media

FIG. 4. (A) Porosity of PETA:HA (100:0), (85:15),
(80:20), and (75:25) scaffolds; (B) maximum compressive
strength of PETA:HA (100:0), (85:15), (80:20), and (75:25)
composites (solid and foam).

For cell-scaffold constructs cultured in stromal media,
PETA:HA (100:0) had the highest metabolic activity after
14 days of culture. PCL:HA (100:0) had the highest levels
of metabolic activity after 21 days of culture in stromal
medium and no significant differences were observed from
this scaffold between any time point. In osteogenic media,
PETA:HA (100:0) scaffolds again exhibited the highest
metabolic activity after 7, 14, and 21 days of culture. PETA:HA (85:15 and 80:20) scaffolds had the next highest
metabolic activity at all time points. PCL scaffolds showed
the lowest levels of metabolic activity after 7, 14, and 21
days of culture (Fig. 5A). The addition of HA to PETA and
PCL scaffolds decreased metabolic activity on constructs
cultured in stromal and osteogenic media. Significantly higher
metabolic activity was observed at all time points for
PCL:HA (100:0) and PCL:HA (80:20) scaffolds cultured in
stromal media compared with osteogenic media. This data is
in agreement with previous studies that indicate that the
metabolic activity of hASCs is expected to decrease as cells
commit to an osteogenic lineage.12,22 No differences in
metabolic activity were seen in PETA:HA composite samples
between stromal and osteogenic conditions. hASCs cultured
on HA-containing scaffolds were expected to begin differentiation into an osteogenic linage regardless of the media
condition, potentially accounting for the differences in metabolic activity between HA-containing and control samples
with respect to media condition. Almost no metabolic activity
was measured in PETA:HA (75:25) scaffolds, likely as a
result of the reduced pore size and interconnectivity.
Total DNA content was quantified using Quant-iT PicoGreen, to analyze the hASC proliferation in scaffolds.
Differences in DNA content, between stromal and osteogenic media conditions, were observed at the 7-day culture
time point for PCL:HA (80:20), PETA:HA (85:15), and
PETA:HA (80:20) composite scaffolds. When comparing
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samples within the stromal media treatment condition, it can
be observed that the PETA:HA samples had significantly
fewer cells than the PCL or PETA control. The most pronounced difference in DNA content was between PCL:HA
(80:20) composites and PETA:HA scaffolds in stromal
media conditions (Fig. 5B), where the DNA content in PCL
(80:20) scaffolds was significantly higher than PETA:HA
composites. At 14 and 21 days, levels of DNA content observed in both PCL scaffolds and the pure PETA scaffolds
were significantly higher than the PETA:HA composites, in
stromal media conditions. Within the osteogenic media
treatment groups, the PETA:HA scaffolds showed slightly
increased DNA content compared with the PCL:HA scaffolds, but all scaffolds contained a similar number of cells.
Quantitative real-time polymerase chain reaction

Bone morphogenic proteins, known to regulate osteogenesis, act on the transcription factor core binding factor alpha 1
(Cbfa1) and result in the activation of osteoblast-related
genes, such as ALP and OCN.17,23 The expression of these
genes is commonly used as early and middle stage markers of
osteogenesis, respectively.24 Quantitative real-time polymerase chain reaction was used to assess the expression of
ALP at the 7-day time point and OCN at 14- and 21-day time
points (Fig. 5C). Based on previous studies, ALP expression
in hASCs decreased dramatically after 7 days in culture and
was therefore not measured at the 14- and 21-day time points
in this study.12,24 The differences in the expression of ALP
and OCN in hASCs cultured on scaffolds in stromal and
osteogenic media are represented in Figure 5C. The cells on
PETA:HA (85:15) and PETA:HA (80:20) scaffolds showed
similar expression of ALP at 7 days and were significantly
higher than all other PETA and PCL scaffolds. Additionally,
hASCs on pure PETA scaffolds had higher ALP expression
than pure PCL control scaffolds. While hASCs cultured on
PCL:HA (80:20) scaffolds had higher ALP expression than
pure PETA or PCL, the expression was still lower than PETA:HA (85:15) and PETA:HA (80:20) scaffolds. Moreover,
the expression of the OCN marker could only be observed at
21 days of culture, with little expression at 14 days regardless
of treatment. The OCN expression level demonstrated in
hASCs as a function of scaffold type was similar to that of
ALP expression with maximal OCN expression observed in
PETA:HA (85:15) and PETA:HA (80:20) followed closely
by OCN levels in PCL:HA composites. Consistent with the
previously described results, cells cultured on the PETA:HA
(75:25) sample did not demonstrate substantial expression of
either marker, likely the result of poor cell proliferation/
survival associated with the lack of a porous and interconnected structure.

FIG. 5. (A) Relative metabolic activity of human adiposederived mesenchymal stromal cells (hASCs) on PETA:HA
(100:0), (85:15), (80:20), and (75:25) scaffolds; (B) relative
DNA content of hASCs on PETA:HA (100:0), (85:15),
(80:20), and (75:25) scaffolds; (C) real-time quantitative
reverse transcription polymerase chain reaction analysis of
alkaline phosphatase (ALP) (7 days) and osteocalcin (OCN)
(14 and 21 days) expression from hASCs on PETA:HA
(100:0), (85:15), (80:20), and (75:25) scaffolds. Color images
available online at www.liebertpub.com/tea

Calcium deposition in hASCs cultured in control
and osteogenic media

The mineralization of different scaffold types was assessed using alizarin red staining, which stains calcium-rich
deposits. hASCs cultured on the PETA composites in stromal and osteogenic media were tested against PCL and
PCL:HA scaffolds (Fig. 6A). As expected, alizarin red
staining was significantly higher in hASCs cultured in osteogenic media compared with samples cultured in stromal
media.12 Also, hASCs cultured in osteogenic media showed
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FIG. 6. Alizarin red stain of PETA:HA as
a function of scaffold composition, media
treatment, and time. (A) Quantitative analysis of staining on scaffolds loaded with
hASCs and cultured in stromal and osteogenic media for 7, 14, and 21 days. (B)
Cross-section of each type of scaffold
stained with alizarin red on 21 days.
Color images available online at www
.liebertpub.com/tea

a significant increase in staining with respect to increased
time in culture. Except for PETA:HA (75:25), all scaffolds
showed significant differences in the calcium deposition at
14 days between stromal and osteogenic media. Both PETA:HA (80:20) and PETA:HA (85:15) cultured in osteogenic media demonstrated significantly increased staining
compared with all other experimental samples and controls.
Almost no calcium deposition, however, was observed at
14- and 21-day culture time points in PETA:HA (75:25)
(Supplementary Fig. S13).

FIG. 7.

In vivo study
Radiography. Observed behavior and weight gain were
normal (90.7 – 5.9 g) for all rats after surgery. Foamed thiolacrylate nanocomposite implants showed some increase in
radiographically detectable opacity 3 weeks after implantation
compared with immediately after surgery, and the opacity
increased further by 6 weeks after implantation. The increasing intensity of bone scaffolds is consistent with
scaffold calcification (Fig. 7). Rats implanted with

Radiographs of in vivo study. Arrows denote location of PETA:HA implants.
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FIG. 8. Micro-CT data of the L4 (top) and L5 (bottom) vertebral bodies from the in vivo study. The light-colored regions
indicate densification in scaffolds. Color images available online at www.liebertpub.com/tea
premolded samples had a lower increase in radioopacity by
6 weeks after implantation compared with rats implanted
with PETA + HA foamed in situ. No evidence of calcification was observed in implants of 0% HA presculpted PETA.
This is consistent with the in vitro osteogenesis target gene
expression results.
Micro-computed tomography. The micro-CT results
support the radiographic findings. The light-colored regions
indicate densification in the scaffolds in Figure 8. In-vivo
and in-situ-polymerized scaffolds had the greatest amount of
densification 6 weeks after surgery.

FIG. 9. Histology analysis
using hematoxylin and eosin
staining. A medial cut was
made on the spinal column of
each rat. The progress of this
specimen guides the analysis of the other specimens.
Arrows denote areas of endochondral ossification. (A,
B, D, F, and I) Rat was
treated with the presculpted
PETA:HA (80:20) scaffold.
(C, E, and G) Rats were
treated with PETA:HA
(80:20) scaffold foamed
in situ. (H) Rat was treated
with PETA:HA (100:0)
foamed in situ. S, scaffold
implants; *, site endochondral ossification. Color images available online at www
.liebertpub.com/tea

Analysis of bone formation using histology. Histological
examination was performed on presculpted PETA:HA
(80:20) and PETA:HA (80:20) foamed in situ, and PETA:
HA (100:0) foamed in situ. The essential step of decalcifying and staining the spinal column poses a problem in
analyzing tissues for bone formation evaluating the calcified
areas. For this reason, tissue morphology is considered a
reliable parameter to measure bone formation.25 Each cohort
was examined 6 weeks postoperative.
Treatment cohort 1 [presculpted PETA:HA (80:20)]
proved to be biocompatible, support cell growth, and induce
osteogenesis in tissue growing into the foam structure.
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Figure 9A shows that the PETA:HA (80:20) implant is
partially demarcated by fibrosis and multifocal fibrocartilage
formation, which incorporates multifocal, small areas of
endochondral ossification. Figure 9D contains the implant
surrounded by fibrous tissue, fibrocartilage, and peripheral
endochondral ossification. The appearance of cells chondrocytic in appearance, a tide mark, and an ossified site
present around the implant site indicate that the PETA:HA
(80:20) scaffold has the potential to induce endochondral
ossification. Figure 9B shows that the polymer implant is
segmentally demarcated by fibrous and fibrocartilagenous
tissues with an ossified rim blending into pre-existing trabecular bone. The findings in Figure 9B are further supported by Figure 9I and F.
Treatment 2 (PETA:HA 80:20 in situ) was also shown to
be biocompatible, support bone growth, and induce osteogenic differentiation. In cohort 2, histological changes are
characterized by osteogenic activity around the implant site.
Figure 9C shows a large accumulation of polymer implant
near the skeletal muscle of the rat, surrounded by a thin
layer of fibrous tissue with a focal area also containing
macrophages. Figure 9E shows the presence of a cavitation
lined by one to three layers of spindled cells (fibroblasts)
containing the scaffold and a sprouting nidus of endochondral ossification. Figure 9G shows that in the area adjacent
to the polymer-occupied cavitation, there are fibrous tissues
and a region of endochondral ossification.
Histological analysis of cohort-3 PETA:HA (100:0) indicates that the lack of nanoscale HA reduces the osteogenic
properties of the scaffolds. In Figure 9H, the scaffold is
surrounded by a very thin layer of fibrous tissue, indicating a
reduction in the formation of organized tissue in the implant
region.
Discussion

Bone tissue engineering involving polymer/ceramic composites presents an attractive alternative approach to the
repair and regeneration of damaged or traumatized bone
tissue.1,26 Several studies have previously explored the potential use of thiol-acrylate chemistry for biomedical devices, but radical-based photoinitiators are usually used to
drive the polymerization process.12,27,28 A nonradical-based
polymerization method is potentially less cytotoxic and
therefore more amenable to in situ polymerization. The
amine-catalyzed Michael addition for thiol-acrylate polymerization described in this study has potential advantages
compared to photoinitiated reactions because the chain
propagation does not require a free radical initiator during
the polymerization reaction. The mechanism of this aminecatalyzed reaction has been previously investigated.6,29 The
general reaction occurs via the formation of a catalyst/
comonomer molecule by the Michael addition of a secondary amine across the alkene end group found in acrylate
monomers. The in situ catalyst produced reacts with a trifunctional thiol and trifunctional acrylates forming a highdensity crosslinked copolymer. The step growth nature and
the incorporation of the tertiary amine catalyst reduce concerns about potential leaching of free radical initiators and
unreacted monomer. This reaction, therefore, is potentially
more attractive for in situ polymerization for bone formation
than comparative free-radical-based methods.
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The PCL-based scaffold was synthesized via a thermal precipitation method resulting in pore size, volume, and interconnectivity that are largely independent of solution viscosity.30
Results showed that such characteristics were directly influenced by the viscosity of the stock solution in the polymerization of PETA composites.31 It is well documented that an
interconnected pore structure can help support cell migration,
cell differentiation, nutrient transport,32,33 and, in some cases,
formation of blood vessels.34–36 Because HA was found to
decrease interconnectivity, it was expected that the highest HA
concentration sample PETA:HA (75:25) would not provide a
suitable environment for cell in-growth and nutrient/waste
transport. Electron microscopy images and micro-CT analysis
indicate that PETA:HA (75:25) scaffolds lack interconnectivity
of the void volume providing for cell penetration and nutrient/
waste transport required for cell growth and differentiation. The
analysis of cell viability and expression of osteogenic markers
further supported this hypothesis.
The decreased metabolic activity of PETA:HA composites compared with the PETA control is likely related to
differences in cell function, not cell number, attributed to
osteogenic differentiation of hASCs. The decreased cell
proliferation and metabolic activity also had an inverse relationship with the increased calcium deposition and expression of osteogenic markers. This data further supports
the hypothesis that HA induces osteogenesis, resulting in
decreased metabolic activity and proliferation.37,38
Calcium deposition correlated with the expression of
ALP and OCN in hASCs cultured on PETA:HA (85:15) and
PETA:HA (80:20) scaffolds, which were significantly
greater than PCL:HA (80:20), pure PCL, and PETA control
scaffolds in both media conditions, providing a further indication that scaffolds composed of PETA may be an appropriate material for the repair of bone defects. Increased
alizarin stain uptake in PETA:HA (80:20) and PETA:HA
(85:15), compared with PCL:HA (80:20), does not correlate
with increased cell density or metabolic activity but does
correlates with increased ALP and OCN expression. PETA
is better able to induce the expression of osteogenic markers
than PCL, but further comparisons at differing concentrations and with other degradable resins are required to test
this hypothesis. Cross-sectional images of PETA:HA
(75:25) scaffolds demonstrate poor alizarin red penetration,
providing further support that the void volume is not substantially interconnected.
Although increasing HA content resulted in reduced pore
size and interconnectivity, it provided a more solid and
stronger structure for the scaffold. Other studies have shown
a similar trend of decreasing porosity with increasing HA
content.39 The increase in compressive strength seen in solid
samples is predictable and similar to that seen with other
nanoscale polymer fillers.40,41 As porosity played no role in
the solid samples, the increase in viscosity with increasing
HA content beyond 15% did not significantly affect the
mechanical strength.
Histological results demonstrated that both the presculpted and foamed in situ PETA:HA (80:20) scaffolds
induced endochondral ossification. Radiography results indicating increased densification further supported these
findings. During the in vivo study, the structure of the
in-situ-polymerized foam sample may have been disrupted
when the surgical site was closed during the surgery. Poor
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porosity and interconnectivity could be the reason why the
densified regions of the radiographs were noncontinuous.
Overall results suggest that PETA:HA scaffolds could be a
suitable substrate for bone regeneration.
Conclusions

By gas foaming thiol-acrylate-based copolymers that
were synthesized via Michael addition with an in situ amine
catalyst, a porous polymeric scaffold with bone-like morphology was developed as a potential graft or augment in
critical-sized bone defect repair. Not only does PETA:HA
composite has substantial porosity and interconnectivity, it
also demonstrates adequate mechanical strength as compared to cortical bone. Compared with PCL:HA composites,
both PETA:HA (85:15) and PETA:HA (80:20) scaffolds
showed higher mineral deposition and ALP and OCN expression level. Overall, the PETA:HA had higher compressive strength and improved cytocompatibility compared
with PCL controls. Mesenchymal cells cultured on PETAbased scaffolds had a greater expression of osteogenic
markers and the scaffolds exhibited significantly greater
mineralization than hASCs cultured on PCL controls. The
in vivo study demonstrated that animals injected with PETA:HA composites showed no signs of surgical site or systemic toxicity and that PETA:HA composites induced
osteogenesis in vivo. Additionally, the study serves as a
proof-of-concept that gas foaming of thiol-acrylate polymers
in vivo may be used to conformally fill irregular-sized defects.
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